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Abstract
Background: In general, immune effector molecules are induced by infection.
Methodology and Principal Findings: However, strong constitutive expression of the cell-autonomous resistance GTPase,
Irga6 (IIGP1), was found in mouse liver, contrasting with previous evidence that expression of this protein is exclusively
dependent on induction by IFNc. Constitutive and IFNc-inducible expression of Irga6 in the liver were shown to be
dependent on transcription initiated from two independent untranslated 59 exons, which splice alternatively into the long
exon encoding the full-length protein sequence. Irga6 is expressed constitutively in freshly isolated hepatocytes and is
competent in these cells to accumulate on the parasitophorous vacuole membrane of infecting Toxoplasma gondii
tachyzoites.
Conclusions and Significance: The role of constitutive hepatocyte expression of Irga6 in resistance to parasites invading
from the gut via the hepatic portal system is discussed.
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Introduction
In general, immune resistance genes show low rates of
constitutive transcription, and rely on signals generated via
infection for their transcriptional induction. The most powerful
mediator of elevated transcription of resistance genes is interferon
(IFN) c, secreted early in the response to pathogens by natural
killer (NK) and NKT cells and later by T helper 1 (Th1) and
cytotoxic T cells (TC1) of the adaptive immune system [1]. The
immunity-related GTPase (IRG) family of GTPases, responsible
for cell-autonomous immunity against a variety of intracellular
pathogens [2,3], has seemed to be no exception to this
generalization. In our own report of the identification of several
IRG proteins [4] we documented strong induction of these
proteins in the liver 24 hours after infection with the strongly
immunostimulatory pathogen, Listeria monocytogenes, and showed
that this induction critically depended on the presence of the
IFNc-receptor. Similarly, IRG proteins were strongly induced by
IFNc in tissue culture cell lines [4,5]. Similar conclusions were
reached in a histological study of the BALB/c mouse spleen during
the course of infection with Listeria monocytogenes, where Irga6
(IIGP1) was seen to be induced in several cell types shortly after
infection, but no expression was reported before infection [6].
Nevertheless, there are several reports on constitutive expression of
members of the IRG family in mice. Taylor reported constitutive
expression of Irgm3 (IGTP) in the thymus [7], with similar results
noted for Irgb6 (TGTP), while there have been independent
reports of expression of IRG proteins in haemopoietic stem cells
[8,9]. In none of these cases was it clear whether the apparently
constitutive expression was in fact due to local IFNc expression of
unknown cause in these lymphomyeloid tissues, rather than to
truly IFNc-independent expression.
In this report we show that Irga6, contrary to earlier
conclusions, is in fact strongly and constitutively expressed in
mouse liver. Furthermore, this expression is independent of IFN
signalling and is driven by a typical hepatocyte-specific promoter
upstream of a dedicated 59-untranslated exon (exon 1B). Irga6 is
however, also strongly induced by IFNc, as correctly reported
earlier, and this is due to a second, IFN-specific promoter
upstream of a second, dedicated 59 exon (exon 1A). These results
provide a rationalization of our earlier observations on the
transcript structure of Irga6, where we noted that the EST
database contained clones with identical coding sequences but
different 59-untranslated (59-UT) sequences consistent with
alternative 59 exon usage, and were able to locate the two
corresponding exons upstream of the coding exon (exon 2) [10].
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6787With the exception of Irgc ([10] and Rohde in preparation), all
mouse IRG proteins are probably involved in a cell-autonomous
resistance mechanism against intracellular pathogens. Irga6
contributes to interferon-induced immunity against Toxoplasma
gondii since expression of a dominant negative mutant of the
protein inhibits interferon-induced resistance to the parasite [11].
Furthermore, two independent mouse strains with disruption or
loss of the Irga6 gene show higher susceptibility to infection with
the avirulent ME49 strain of T. gondii (unpublished results). We
show here that endogenous Irga6, constitutively expressed in
hepatocytes, is able to accumulate on the parasitophorous vacuole
membrane of infecting ME49 strain T. gondii, but is ineffective in
initiating the vacuolar rupture typical of complex IFNc-induced
responses in which multiple IRG proteins are expressed at high
levels [11–14].
Results
Constitutive expression of Irga6 in liver
When Irga6 was first described [4] we showed by Northern blot
that the transcript was massively induced in the liver 24 h after
infection with Listeria monocytogenes. The autoradiographic exposure
of that Northern blot was optimized to obtain the best resolution
between transcript levels from uninfected and infected liver, and
was not normalized to any other tissue or cell type. The image
conveyed the impression that Irga6 is transcribed at very low
levels, if at all, in the uninfected liver compared with the infected
liver. This is what we believed, and the conclusion was fully
compatible with parallel data obtained from tissue culture cells
stimulated with IFNc for 24 h or left unstimulated. Again, the
autoradiographic image was optimized to obtain clear resolution
between IFNc-induced and uninduced transcript levels and not
normalized to the liver data. We have now revisited that
experiment and present a new Northern blot of the same liver
RNA pool that was used in the previous study, compared with
RNA from IFNc-induced and uninduced mouse fibroblasts, in this
case normalized to GAPDH signal intensity in the two assay
systems. The Northern blot and its quantitation are shown in
Fig. 1A. The new analysis shows that Irga6 is indeed induced in
fibroblasts from a very low expression level, but also shows that the
expression level in normal liver from uninfected mice is already
even higher than the level reached in IFNc-induced fibroblasts.
This already high level was further enhanced another 10-fold 24 h
after L. monocytogenes infection. The elevated expression in liver
following L. monocytogenes infection is due to stimulation by
IFNc, since no such effect followed L. monocytogenes infection of
IFNc-receptor-deficient mice. In addition, however, the high basal
expression of Irga6 in liver was not significantly affected by loss of
the IFNc receptor, providing a strong indication that basal Irga6
transcription in the liver is not dependent on intrinsic IFNc
stimulation of whatever cause.
The high level of constitutive transcription of Irga6 in the liver
was also found to be associated with a high level of Irga6 protein
expression in this organ, as shown by Western blot in Fig. 1B.
Protein levels relative to calnexin were equal to or higher than
those in IFNc-induced L929 fibroblasts. Constitutive Irga6 protein
expression in the liver was also independent of immunological
maturity: levels in 123 day old mice were no different from levels
in mature mice. By in situ hybridization (Fig. 1C) and
immunohistology (Fig. 1D) the expression of both RNA and
protein of Irga6 was confirmed in liver sections, controlled in the
case of in situ hybridization by the sense probe and in
immunohistology on liver sections from an Irga6-deficient mouse
derived by gene targeting [15]. The results of both assays
confirmed the expression of Irga6 in the liver and both assays
also clearly demonstrated that the protein is universally expressed
in hepatic parenchymal cells.
Constitutive expression of Irga6 in other organs
By Western blot (Fig. 2A) Irga6 is also expressed in untreated
mice at widely different levels in other organs, notably heart, skin,
spleen and thymus, although nowhere as strongly as in the liver.
By immunohistology (Fig. 2B), Irga6 expression was found in some
cardiac myocytes but not others. In spleen, Irga6 was expressed
exclusively in the red pulp, and in the thymus in the medulla.
Surprisingly, an earlier immunohistological analysis of the spleen
using a monoclonal antibody (5D9) directed against Irga6 did not
report the expression of Irga6 in the red pulp [6]. Occasional
patches of Irga6 expression were found in kidney tubular
epithelium. No defined compartment expressing Irga6 could be
identified in skin despite significant expression in this organ (not
shown and Fig. 2A). We considered the possibility that at least
some of this apparently constitutive expression of Irga6 might be
due to local expression of IFNs, although our observations (Fig. 1)
showed this was not the case for the liver. Western blots on organ
lysates from single IFNc-receptor-deficient (IFNGR), single IFN-
type I receptor deficient (IFNAR) and double-deficient (IFNAGR)
mice were compared with wild type, normalized to calnexin
(Fig. 3). As expected, very high constitutive Irga6 expression in the
liver was unaffected by single or double IFN receptor deficiency
and high expression also persisted in the heart. In skin, spleen,
intestine and thymus, however, loss of the IFN receptors markedly
reduced the detectable Irga6 signal, with the greatest reduction
being in the double receptor deficient mouse. We conclude that
Irga6 expression in normal, not intentionally infected, mice arises
from two causes, genuinely constitutive expression in liver
parenchymal cells and probably also cardiac myocytes, and
expression induced by local production of type I and Type II
IFNs in skin, spleen and thymus in unidentified cell types.
Genomic and transcriptional structure of Irga6: two
alternative 59 untranslated exons
The exceptionally high, apparently IFN-independent, expres-
sion of Irga6 in liver parenchymal cells suggested that Irga6
transcription in this organ must be under completely different
regulation from that typical of fibroblasts and other tissues where
interferons appeared to dominate control of Irga6 expression. The
genomic organization of the Irga6 gene was reported earlier [10].
In that study we noted that transcription of Irga6 was alternatively
initiated upstream of two distinct and widely separated 59-
untranslated exons, which we here name exon 1A and exon 1B
respectively for the upstream and downstream exons. These
observations suggested that a closer analysis of the 59 region of the
Irga6 gene could be of interest in the present context. Alignments
of ESTs from the public databases allowed us to identify Irga6
exons 1A and 1B and infer probable start-points for transcription
(Figure S1).
The sequences of exons 1A and 1B diverge considerably in the
59 region but converge towards near identity close to the splice
donor site (Figure S1). Both exons normally splice to the same
splice acceptor upstream of the long coding exon 2, 20 bp
upstream of the initiator codon (Figure S1). Further short
untranslated regions can be found very occasionally introduced
between Exon 1A or Exon 1B and the ORF-encoding exon 2
(unpublished results). These unique events are too rare to be
dignified by the term ‘‘alternative splicing’’ and too inconsistent to
earn the regions concerned the titles of ‘‘exons’’. A peculiar case
recently reported [16] was an Irga6 cDNA carrying both exon 1A
Expression of Irga6 in Liver
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(NM_001146275). This, till now unique, structure is unlikely to
be of any biological significance.
Fig. 4A shows diagrammatically the intron-exon structure of the
Irga6 gene and the organization of the 1A and 1B promoters (see
also Fig. 5 and Table S2). In the genomic structure of Irga6 exons
Figure 1. Irga6 is constitutively expressed in healthy mouse liver. A. Northern blot analysis of Irga6 RNA expression. Total RNA was extracted
from livers of wild-type C57BL/6J or IFN-c receptor knock out (IFN-cR
2/2) mice, which were either untreated (2) or had been infected with Listeria
monocytogenes at LD50 24 h earlier (+). The Irga6 ORF labeled with [a-
32P]-dCTP was used as probe. L929 mouse fibroblasts, either unstimulated (2)
or stimulated (+) with 200 U/ml IFNc for 24 h, were used as controls. GAPDH was also detected as loading control. The y-axis of the histogram
presents relative units of Irga6 signal normalized to GAPDH. B. Western blot analysis of Irga6 protein expression. Detergent lysates of livers prepared
as described in Materials and Methods (100 mg/lane) from CB20 baby (3 or 4 days, 3 individuals) and adult mice (4 or 6 weeks, 4 individuals) were
probed for Irga6 protein with mAb 10D7. L929 mouse fibroblasts (5,000 cells/lane) stimulated with 200 U/ml IFNc for 24 h were used as positive
control. Calnexin protein was probed as loading control. An endoproteolytic cleavage product of calnexin is apparent in some lanes, especially Lane
2. C. In situ hybridization analysis of Irga6 RNA expression. Livers from adult C57BL/6 mice were fixed, embedded in paraffin and cut into 6 m sections.
DIG-labeled single-stranded RNA sense and anti-sense probes were synthesized by in vitro transcription using the 59 end of the Irga6 ORF (12490 bp)
as template. The hybridized RNA probes were detected with anti-DIG antibody to give a blue stain. For details see Materials and Methods. D.
Immunohistochemical analysis of Irga6 protein expression. Paraffin sections of livers from adult C57BL/6 wild-type (WT) and Irga6
2/2 mice were
probed for Irga6 protein with rabbit anti-Irga6 antiserum 165/3. Specific antibody binding was detected histochemically as described in Materials and
Methods to yield a green stain. Nuclei were counterstained in red.
doi:10.1371/journal.pone.0006787.g001
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long coding exon 2 begins 7018 bp downstream of the 39 margin
of exon 1B. Definition of the transcriptional start sites for exons 1A
and 1B (Figure S1, see also above) allowed for the identification of
putative transcription factor binding sites. In our previous analysis
5 IFN response elements were found upstream of exon 1A,
including 2 ISREs and 3 GAS sequences, and single GAS and
ISRE sequences upstream of exon 1B (Bekpen et al, 2005). A
search for liver specific response elements in the 1000 bases
upstream of exons 1A and 1B now revealed that exon 1B is
preceded by an apparently canonical liver-specific promoter, while
no liver response elements were found closer than 900 bases
upstream of exon 1A (Fig. 4A). Alignments of the 7 hepatocyte
nuclear factor (HNF) promoter elements found in the 1B promoter
with the consensus sequence for each element are shown in Fig. 4B.
Not only the identity of the HNF elements, but also their array on
the putative promoter conform to the pattern of typical liver-
specific promoters [17,18].
Figure 2. Irga6 is expressed in many mouse tissues. A. Western blot analysis of Irga6 protein expression. Detergent lysates from liver, heart,
skin, spleen, intestine, thymus, lung, testis, kidney and brain of wild-type C57BL/6 mice were probed for Irga6 protein using mAb 10D7. Loading for all
tissues was 50 mg/lane except for skin, which was 150 mg/lane. L929 mouse fibroblasts (5,000 cells/lane) untreated (L929 IFN-) or stimulated (L929
IFN+) with 200 U/ml IFNc for 24 h were used as negative and positive controls. Calnexin protein was probed as loading control. An endoproteolytic
cleavage product of calnexin is apparent in some lanes, especially in the Heart and Kidney samples. B. Immunohistochemical analysis of Irga6 protein
expression. C57BL/6 WT and Irga6
2/2 adult mouse kidney, heart, spleen and thymus were embedded in paraffin and cut into 6 m sections. Irga6
protein was probed with mAb 10D7 and detected histochemically to give a green stain. Nuclei were counterstained in red. Frames and arrows show
enlarged sections.
doi:10.1371/journal.pone.0006787.g002
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and IFN-inducible Irga6 in liver, two primer pairs were designed
with 59 primers specific for exon 1A and exon 1B respectively, and
a common 39 primer in exon 2 (see Materials and Methods) for use
in quantitative real-time PCR on cDNA from uninfected and L.
monocytogenes-infected mouse livers. The result (Fig. 4C), expressed
in relative units, showed that essentially all the Irga6 transcripts in
uninfected liver were initiated from the 1B promoter, while
essentially all of the Irga6 transcripts in L. monocytogenes-infected
liver were initiated from the 1A promoter. The relative expression
of the 1A-derived transcript was increased approximately 800-fold
by L. monocytogenes infection. Perhaps unexpectedly, the expression
of the 1B-derived transcript was apparently not noticeably affected
by the enormous increase in transcription from the 1A promoter.
Indeed, a marginal increase was measured.
A differential PCR analysis of the use of the 1A and 1B
promoters for constitutive Irga6 expression in other organs of
uninfected animals showed extremely low transcript levels
compared with liver, and no consistent organ-specific preference
for the 1A or 1B promoters (Fig S2). Unexpectedly, constitutive
expression of Irga6 in the heart was not restricted to use of the 1B
promoter, thus the explanation for this constitutive expression is
clearly different, and would justify an intensive analysis.
Exon1B, associated with the hepatocyte-specific Irga6 promot-
er, has homologues in the 59 regions of two other genes of the
IRGA cluster on mouse chromosome 18. Irga1 and Irga2, whose
coding sequences cluster phylogenetically with Irga6 [10], both
possess potential 59 exons with strong sequence homology to exon
1B of Irga6 (Fig. 5A and B). In the case of Irga1 the homology to
the exon 1B region of Irga6 continues upstream across the whole
region populated by HNF binding sites, while in Irga2 only the
distal cluster of HNF binding sites is conserved (Table S1). Both
Irga1 and Irga2 are probably functionally pseudogenes [10]. For
unknown reasons, Irga1 fails to splice normally from the 59-UT to
the 39 coding exon, and also has two short frame-shifting deletions
in exon 2 which would lead to an abnormal truncated protein.
Irga2 has a surprising splicing arrangement, using exclusively the
59-UT exon of Irga1 rather than its own 59 exon (which is
identified in Fig. 5A by homology), and then leapfrogging the
Irga1 coding exon and the entire intergenic region before splicing
Figure 3. Irga6 expression in different mouse tissues is influenced differentially by IFNs. Western blots for Irga6 protein on detergent
lysates of organs from WT 129Sv mice or type I IFN receptor knock-out (AR), type II IFN receptor knock-out (GR), or double knock-out (AGR) mice, on
the same genetic background. Blots were probed with mAb 10D7. The organs indicated were taken from 4 individuals for the AGR mice and 2 for the
WT, AR and GR mice. The loading for all tissue lysates was 150 mg/lane except for liver, which was 80 mg/lane. L929 mouse fibroblasts (5,000 cells/
lane) unstimulated (2) or stimulated (+) with 200 U/ml IFN-c for 24 h were used as controls. Calnexin protein was probed as loading control.
doi:10.1371/journal.pone.0006787.g003
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unusual splicing arrangement are apparently complete, but we have
till now been unable to detect an Irga2 protein product in IFNc-
induced cells derived from Irga6
2/2 fibroblasts using a rabbit anti-
Irga6 antiserum that cross-reacts strongly on bacterially-expressed
Irga2 (unpublished results). Irga2 transcripts of this type are strongly
induced by IFNc, presumably from the ISRE and GAS sites located
in the Irga1 exon 1 promoter [10]. The reason for the absence of an
Irga2 protein product in vivo is not known. The bottom line,
however, isthat Irga6 istheonly functional IRGA proteinexpressed
from its constitutive liver-specific 1B promoter. The remaining
genes in the Irga cluster have 59 untranslated exons homologous to
the 1A exon of Irga6, preceded by clusters of canonical interferon-
inducibleelements([10]andFig.5Aalignment).Thecompleteexon
organization of the Irga cluster on chromosome 18 is given in
Fig. 5C, along with a detailed description
Figure 4. Irga6 constitutive expression in liver uses a different promoter from that used for IFN induction. A. Scheme of Irga6 gene
and promoter structure. The lengths of exons 1A, 1B and the long coding exon 2 are 104 bp, 107 bp and 2233 bp respectively (see also Figure S1).
The distance between 1A and 1B is ,6.5 kb; between 1B and coding exon is ,7.0 kb (see also Table S2). Putative transcription factor binding sites
(GAS, ISRE, C-Fos and HNF) within 500 bp and 600 bp upstream respectively of the Irga6 1A and 1B exons are indicated. Binding sites on the negative
strand are marked by (2). B. Putative HNF sites in the Irga6 1B promoter. HNF-1 and HNF-3b sites identified as described in Materials and Methods
were aligned to the consensus sequences and the position of each sequence upstream of the putative transcription start is given. Bases identical to
consensus sequences are shaded in black. Binding sites on the negative strand are marked by (2). D=A/G/T, H=A/C/T, N=A/C/G/T, W=A/T, K=G/T,
Y=C/T. C. Real-time PCR analysis of transcript expression of Irga6 carrying the 1A or 1B exons. mRNA from liver of C57BL/6J mice either untreated
(Liver) or infected with Listeria monocytogenes at LD50 for 24 h (Liver+Listeria) were subjected to real-time RT-PCR. Relative units here were defined by
the expression level of Irga6 transcript normalized to that of the mouse HPRT. The left hand graph with an expanded scale shows the predominant
usage of the 1B promoter in the control liver (Liver). In the right hand graph, the date from the control liver (Liver) is redrawn on the reduced scale
necessary to display the enormous increase in transcription of the 1A promoter in the infected liver (Liver+Listeria). It is important to take account of
the scale difference between the two graphs.
doi:10.1371/journal.pone.0006787.g004
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To confirm the expression of Irga6 in hepatocytes, a number of
in vitro established cell lines of hepatic origin were assayed for
constitutive Irga6 expression. Very low levels of Irga6 were
detected, while in all cases Irga6 could be induced with IFNc
(Fig. 6A and data not shown). Thus the elevated constitutive
expression of Irga6 found in vivo appeared to reflect a
differentiated property of hepatocytes that, in common with
other differentiated functions of these cells, is lost on in vitro
culture [19–21]. This could be directly confirmed by cultivation
of primary hepatocytes isolated from mouse liver. The Western
blot shown in Fig. 6A (upper panel) shows that expression of
Irga6 in isolated primary hepatocytes is higher than the calnexin
control signal. This intensity of expression is maintained up to
6 h of culture but thereafter drops markedly. The decline in
expression at 24 h can, however, be prevented and indeed
reversed if the hepatocytes are cultured for this period with IFNc.
The expression of Irga6 in primary hepatocytes reached a
minimum by 2 days of culture and remained essentially stable at
this low level for up to 5 days thereafter (Fig. 6A, lower panel).
The residual expression level after 2 or more days of hepatocyte
culture was only slightly higher than that seen in an unstimulated
line of hepatocyte-derived tissue culture cells, TIB73. Other IRG
proteins were also detected above background in primary
Figure 5. Phylogenetic relationships among the 59-UT exons of the IRGA genes. A. Alignment of the putative 59 exons of the IRGA genes.
Irga5, which is not listed, is a degraded pseudogene without transcript [10] (see also below). The 59 exons fall into two sequence classes homologous
to the exon 1A and exon 1B of Irga6 respectively. Exon 1A and 1B of Irga6 have been presented in detail in Figure S1. Exon 1 of Irga3, Irga4, and Irga8
are all inferred from EST sequences and confirmed against the chromosome 18 genomic contig NT_039674.7. The predicted exon 1 of Irga7 is derived
by homology from the other 1A exons. It is positioned and oriented correctly relative to the Irga7 gene but has not yet been recovered from an EST
pool. B. Average distance phylogram based on percentage identity, relating the exon 1 sequences of the IRGA family of genes shown in Fig. 5A
above. The numbers recorded above each branch give the percentage difference in sequence along the branch. The distinction between 1A and 1B
exons is clear. The predicted exon 1 of Irga7 is an outlier in the 1A group, consistent with the possibility that Irga7 is a pseudogene (see Fig. 5C ). C.
Scale map of the IRGA gene cluster on chromosome 18 of the C57BL/6 mouse. The complete sequence domain of the IRGA genes was extracted from
the chromosome 18 genomic contig, NT_039674.7. The length of the whole cluster from the 59 nucleotide of exon 1 of Irga1 to the 39 nucleotide of
the ORF of Irga8 is 230,910 nucleotides. In each case, the position of the 59-UT exon 1 is shown in black and the long exon 2 containing the ORF in
red. Arrows above each 59 exon indicate the direction of transcription. The 39-UT region of exon 2 is not indicated. The homology group, 1A or 1B (see
Fig. 5A and 5B above), is indicated for each 59-UT exon. The 1B exon upstream of Irga1 is found associated only with ESTs (e.g. AK149583.1 and
AK149556.1) containing the ORF of Irga2, indicated by the oblique transcription orientation arrow. The ORF of Irga1 itself is interrupted by two frame
shifts and cannot generate a full-length Irga1 protein. Furthermore, Irga1 is found in databases exclusively associated with incorrectly-spliced ESTs
(e.g. BI658674, BG915086). The transcriptional orientation indicator for Irga2 shows no terminal arrowhead because although the 1B exon of Irga2 is
clearly identified by homology no transcripts have been found containing this exon. Irga2 is found exclusively associated with exon 1 of Irga1. Irga5
was described as a pseudogene earlier [10]. The long exon was identified by homology to exon 2 of other IRGA genes but contains no full-length
ORF. No ESTs have been described from Irga5 and no 59-UT exon 1 could be identified by homology to either exon 1A or 1B. Irga7 encodes a full-
length ORF in exon 2, and the 59-UT was readily identifiable by homology. However no ESTs encoding Irga7 have been found and no transcripts
corresponding to Irga7 were detected in IFN-stimulated L929 fibroblasts (Bekpen, 2005). Thus Irga7 is probably a pseudogene in the C57BL/6 mouse
and in L929 (C3H/An strain) fibroblasts.
doi:10.1371/journal.pone.0006787.g005
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shown) were significant but below the expression levels in IFNg-
induced fibroblasts. Irgm3 was barely detectable above back-
ground (Fig S3 and data not shown). All of these proteins were
strongly inducible in primary hepatocytes by IFNg (Fig S3 and
data not shown)
Immunofluorescence analysis of the expression of Irga6 in
freshly isolated primary hepatocytes confirmed the high level of
expression (Fig. 6B). The Irga6 signal accurately co-localised with
the signal for the ER protein, calnexin. No significant expression
of hepatocyte Irga6 was apparently associated with the distributed
Golgi elements of these cells.
Accumulation of Irga6 on the parasitophorous vacuoles
of T. gondii infecting isolated primary hepatocytes
As previously reported, Irga6 and other IRG proteins
accumulate rapidly on the parasitophorous vacuoles of infecting
T. gondii in IFNc-induced cells [11,22]. We were interested to
know whether the constitutively expressed Irga6 in primary
hepatocytes could also accumulate on the T. gondii PV. Freshly
isolated primary hepatocytes were therefore infected with T.
gondii strain ME49 and Irga6 distribution was examined by
immunofluorescence. Intense ring-shaped fluorescence of Irga6
surrounding some infecting T.gondii was observed (Fig. 7A). It
was, however, also noted that the proportion of Irga6-coated T.
Figure 6. Constitutive and induced expression of Irga6 in mouse primary hepatocytes. A. Western blot analysis of Irga6 protein
expression. C57BL/6 mouse primary hepatocytes were isolated as described in Materials and Methods. Protein lysates of liver or primary hepatocytes
cultured and harvested at indicated hours (h) or days (d) post-isolation were probed for Irga6 protein with mAb 10D7 by Western blotting.
Hepatocytes were cultivated with (24h+) or without (24h-) 200 U/ml IFN for 24 hours. L929 and TIB73 cells (5,000 cells/lane) stimulated with IFNc
(200 U/ml) for 24 h were used as positive control. Calnexin protein was probed as loading control. B. Immunofluorescence analysis of Irga6 protein
expression in hepatocytes. C57BL/6 mouse primary hepatocytes were isolated, cultured for 6 h, fixed and immunostained for Irga6 protein. Double
staining using either Irga6 mAb 10E7 (green) and calnexin rabbit antiserum (red) (upper row) or Irga6 rabbit antiserum 165/3 (red) and anti-GM130
mAb (green) (lower row) were performed. Nuclei were counterstained with DAPI (blue).
doi:10.1371/journal.pone.0006787.g006
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in IFNc-induced fibroblasts and other cells, which is normally in
the range from 50% to 70% [11]. In unstimulated primary
hepatocytes Irga6 was the only IRG protein that was detected on
the T. gondii PVM. Irgb6 and Irgd could not be detected at the
PVM despite their significant basal expression levels (data not
shown). In IFNc-stimulated primary hepatocytes, however, the
normal pattern of PVM loading with these IRG proteins was
observed, and the typical quantitative hierarchy of loading
(Irgb6.Irga6.Irgd.Irgm3) described in detail elsewhere (Kha-
minets et al, in preparation), was restored (not shown). In IFNc-
treated cells, T. gondii PVs coated with IRG proteins became
disrupted during the first few hours after infection [11,14]. No
disruption of Irga6-coated T. gondii PVs was observed in primary
hepatocytes without IFNc treatment, but disrupted vacuoles were
readily seen in infected IFNc-induced primary hepatocytes
(Fig. 7A). IFNg-induced primary hepatocytes were also able to
control T. gondii replication (Fig. 7C).
Discussion
We have shown that Irga6, an IFN-inducible member of the
immunity-related IRG protein family in the C57BL/6 mouse, is
also expressed constitutively and strongly in normal mouse liver
through use of a dedicated, liver-specific promoter. IFN-inducible
and constitutive expression are initiated from separate promoters.
Each promoter is upstream of a dedicated 59 exon that splices into
the single long protein-coding exon 2 just upstream of the
translation start. Thus the proteins derived from the two
promoters are identical. Inducibility by interferons is a strong
indication for a role in induced resistance to infection [1], and the
strong IFN inducibility of Irga6 and all the other mouse IRG
Figure 7. Constitutive and IFNc stimulated Irga6 proteins accumulate around T. gondii PVs in mouse primary hepatocytes. A.
Immunofluorescence analysis of Irga6 protein accumulation at T. gondii vacuoles in murine primary hepatocytes. C57BL/6 murine primary
hepatocytes were freshly isolated and either stimulated (+IFNc) for 12 h with 200 U/ml IFNc or left untreated and cultured for 3 hours (-IFN-c). The
cells were inoculated with T. gondii (strain ME49) at a MOI of 3 for 2 h, fixed and immunostained. Double staining for Irga6 with mAb 10E7 (green)
and GRA7 with anti-GRA7 mAb (red) was performed. Nuclei were counterstained with DAPI (blue). White arrowhead indicates a disrupting vacuole. B.
Quantification of Irga6 positive T. gondii PVs in the experimental setup described in (A). Percentages of Irga6 positive PVs per total intracellular T.
gondii vacuoles are given. Intracellular parasites were identified by the distinct GRA7 pattern. The means of two or three independent experiments
doi:10.1371/journal.pone.0006787.g007
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countering infections by exogenous intracellular parasites [3].
The high constitutive expression of Irga6 in liver stands in contrast
to that principle and presents something of a paradox. Certainly,
constitutive expression of an early-acting resistance mechanism in
barrier tissues may be considered preadaptive, and it was notable
that a significant level of Irga6 expression was observed in the skin,
although it could not be localised histologically to a specific cell
layer and was in any case substantially lower than the liver-specific
expression. Furthermore the apparent partial dependence of skin-
specific Irga6 expression on IFN action implied by the reduced
expression in IFN receptor-deficient mice may suggest that Irga6
expression in the skin is not primarily constitutive but rather due to
continuous low-level stimulation of immunity in this barrier site.
Low, IFN-dependent expression of Irga6 in lymphoid organs such
as spleen and thymus presumably reflects low-level immune-
related activity. Histologically, expression in red-pulp of spleen
and in medulla of thymus suggests that macrophages may be the
main sites of elevated Irga6 expression though this has not been
investigated directly.
However these considerations do not help to explain the
genuinely constitutive expression of Irga6 at very high levels in
liver parenchymal cells. Here, expression relative to the calnexin
control was higher than in IFN-induced fibroblasts, both at the
mRNA and protein levels, and was not detectably reduced by loss
of either or both the type I and type II IFN receptors. The near
exclusive use of the hepatocyte-specific 1B promoter for IFN-
independent expression further confirms that this expression is
indeed truly constitutive.
To rationalize constitutive Irga6 expression in the liver, it may
be argued that the liver is in some sense a barrier organ for
pathogens such as L. monocytogenes and Plasmodium that above all
favour liver parenchymal cells for their initial proliferative episode.
Liver is an early site of infection in peroral T. gondii infection after
dissemination from the wall of the intestine ([23] and Oliver
Liesenfeld, personal communication) presumably via the hepatic
portal system. However expression of Irga6 at high levels in
hepatocytes in the absence of IFNc, as shown here, raises a further
complex issue. We have shown elsewhere that both the resting
localisation of Irga6 in cells and its ability to accumulate normally
on the T. gondii parasitophorous vacuole is dependent on co-
expression of multiple IFN-inducible members of the IRG protein
family ([24]; Khaminets et al, in prep). At first sight, Irga6
expressed in resting hepatocytes appears to break this rule. The
protein is accurately localised on the endoplasmic reticulum, and is
able to accumulate on the T. gondii PVM. However the number of
vacuoles showing detectable Irga6 accumulation is abnormally
low, a number that is substantially restored towards expected levels
by prior induction with IFNc. Furthermore, in the absence of
IFNc induction, no disruption of the T. gondii vacuole was
detected, suggesting that a high level of expression of Irga6 alone is
not sufficient to complete the resistance mechanism. We
considered the possibility that other IRG proteins may also be
expressed at measurable levels in hepatocytes, even if not at the
level of Irga6, thus enabling localisation of Irga6 to the ER and
partially enabling access to the T. gondii PVM. Irgb6, Irgm1 and
Irgd were all expressed at detectable though still relatively low
levels. The striking exception is Irgm3, which was essentially
undetectable in unstimulated primary hepatocytes but was
strongly induced by IFNg. Interestingly, Irgm3 is expressed
constitutively in whole liver, but is associated exclusively with
scattered, much smaller cells probably associated with the
sinusoids. These cells are lost during the hepatocyte purification.
We reported inefficient Irga6 loading of the T. gondii PVM earlier
[24] in cells in which Irga6 alone of the effector IRG (GKS
subfamily) proteins was co-expressed with the three regulator
proteins, Irgm1, Irgm2 and Irgm3 [24]. We further showed that
expression of all 3 Irgm proteins was required for loading. We
have since shown that quantitatively normal PVM loading of Irga6
in such reconstruction experiments can be achieved by addition of
normal levels of Irgb6 and/or Irgd (Khaminets et al, in prep). The
anomalies of IRG loading in unstimulated hepatocytes may be
therefore be attributable to the apparently complete absence of
Irgm3 and the relatively low levels of other IRG proteins. Thus
hepatocytes constitutively express an ‘‘unbalanced’’ collection of
IRG proteins that supports only inefficient loading of the T. gondii
PVM. Evidently, the complement of highly expressed IRG
proteins would normalize in hepatocytes as soon as the IFNc
levels begin to rise during infection, and we show that IFNg-
induced primary hepatocytes are able to control T. gondii
replication (Fig S3). Whether early expression of Irga6 alone
accelerates the development of full cell-autonomous resistance is
unclear. An adaptive explanation for the high and dedicated
expression of Irga6 in hepatic parenchymal cells is therefore not
yet available.
An unexpected precedent exists for the complex regulation of
expression of Irga6. The human and mouse RNA-specific
adenosine deaminase, ADAR1, which is a classical Type I
interferon-inducible gene associated with the dsRNA recognition
and degradation pathway, is also transcribed from two distinct
promoters, named exon 1A and exon 1B, each subtending its own
untranslated 59 exon [25–27]. Like Irga6, one of the promoters is
interferon-inducible while the other is expressed constitutively, in
this case in embryos and in the adult brain. Despite the striking
similarities there are also differences between the two situations.
The two Irga6 promoters regulate the synthesis of identical protein
products. The two ADAR promoters, on the other hand, control
the expression of distinct products since the 1A exon behind the
interferon-inducible promoter also contains an initiator methio-
nine, while the constitutively expressed 1B exon does not and
protein translation is initiated from a second methionine codon in
exon 2, generating a shorter protein. Furthermore, there is
evidence that the RNA editing activity of ADAR may be exercised
on host cell mRNA, and that the constitutive form of ADAR1 is
necessary for normal embryonic development. In contrast, mice
carrying a genomic disruption in the Irga6 protein coding region
show no developmental abnormalities and are perfectly viable and
fertile, while showing a significant susceptibility to infection with
an avirulent strain of T. gondii (unpublished results and Liesenfeld,
O, personal communication). It is not excluded that the
constitutive expression of Irga6 in the liver may contribute to a
pathogen resistance function, but our data show that the high
constitutive expression of Irga6 leads only to limited loading onto
the T. gondii parasitophorous vacuole membrane and is unable to
lead to disruption of the vacuolar membrane. For the time being,
therefore, the functional meaning of constitutive expression of
Irga6 in mouse liver remains to be identified.
Materials and Methods
Mice
Specific pathogen-free C57BL/6 and CB20 mice were obtained
from the mouse facility in the Institute for Genetics, University of
Cologne. In Irga6-deficient (Irga6
2/2) mice the entire coding
exon (exon 2) of the Irga6 gene was removed from the C57BL/6
genome by Cre-mediated recombination ([15] and unpublished
results). Type I, Type II and double IFN receptor deficient mice
(IFNAR [28], IFNGR ([29], IFNAGR [30]) on the 129SV
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(Max Planck Institute for Immunobiology, Freiburg and Professor
Hans Hengartner (Institute for Experimental Immunology,
University of Zu ¨rich). RNA preparations from the livers of
C57BL/6 and IFNGR-deficient mice infected i.p. with Listeria
monocytogenes strain EGD at 50% of the lethal dose were described
earlier [4].
Experiments involving mice were performed following the
guidelines given in Licence Nr. 50.203.2-K 13, 21/02 ‘‘Cell-
biological basis of innate immunity’’ issued by the administrative
authority of the City of Cologne.
Serological reagents
Primary serological reagents used were: anti-Irga6 165 rabbit
antiserum (ref), anti-Irga6 mouse monoclonal antibodies (mAb)
10D7 and 10E7 (gifts from Jens Zerrahn, MPIfor Infection Biology,
Berlin), anti-calnexin rabbit antiserum (Biomol, Hamburg), anti-
Gm130 mAb (BD Transduction Laboratory), anti-GRA7 5–241–
178 mouse mAb (gift from R. Ziemann, Abbott Laboratories).
Secondary fluorescent antibodies were goat anti-mouse Alexa 546/
488, goat anti-rabbit Alexa 546/488 (Molecular Probes).
Northern blot analysis
5 mg of total RNA from liver or cells was separated on 1%
agarose/formaldehyde gels and transferred onto Hybond-N+
membrane (Amersham Biosciences) by standard procedures. The
blots were probed with randomly primed [a-
32P]dCTP-labeled Irga6
ORF generated with the Rediprime DNA labeling system (Amer-
sham Life Sciences). The similarly labeled ORF of mouse
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as
a control probe to reveal the amount of loaded total RNA, and the
RNA Millenium Marker (Ambion) was used as a RNA size standard.
Hybridizations were performed overnight at 42uCi nab u f f e r
containing 50% formamide, 56Denhardt’s solution (100 mg/ml
each of Ficoll400, polvinylpyrrolidone and BSA Cohn Fraction V),
56standard saline-phosphate-EDTA (SSPE), 1% SDS, and 10%
dextran sulfate. Membranes were washed under stringent conditions.
The hybridization signal was detected by autoradiography, using
Kodak X-OMAT AR films.
Protein extraction and Western detection
Mouse tissues or cells were snap frozen in liquid nitrogen,
ground fine in a pestle and mortar (only for tissue), weighed and
lysed in the following buffer (150 mM NaCl, 50 mM Tris, 1% NP-
40, 0.1% SDS, 0.5% deoxycholate, 5 mM EDTA, 1% Triton X-
100, pH 8.0) with protein inhibitor cocktail (Complete Mini,
Roche) to a standard final concentration. The lysates were
homogenized by repeated passage through a 20G syringe needle
and cleared by centrifugation (30 min, 23,000 g). The superna-
tants were then subjected to standard western blot analysis.
Histology
Tissue preparation. Mouse tissues were fixed in TBS/4%
paraformaldehyde at 4uC and dehydrated through an ethanol
series at 4uC (50%, 70%, 90%, 96%). Tissues were then
transferred into isopropanol and finally into paraffin:isopropanol
(1:1) solution at 60uC. The isopropanol was evaporated and fresh
paraffin was then replenished several times at 60uC before the
sections were moved to room temperature (RT). The embedded
tissues were cut with a microtome RM 2065 (Leica Microsystems)
into 6 mm thick serial sections.
Immunohistochemistry. Paraffin sections were de-waxed in
xylene and post-fixed in 4% paraformaldehyde for 1 h at RT.
Protein epitopes were then demasked by boiling for 10 min in
10 mM citrate buffer, pH 6.0. Non-specific protein binding and
endogenous peroxidases were saturated with quenching buffer (1%
BSA, 0.3% H2O2 in PBS) for 20 mins. After PBS washing, the
sections were probed with 165/3 antiserum in DAKO diluent
(DAKO, Hamburg). The HRP colour reaction was performed
with the peroxidase substrate kit HistoGreen (Linaris). The nuclei
were counterstained with Nuclear Fast Red.
In situ hybridization. The Irga6 DNA template for the RNA
probe were amplified using antisense (59-CGGGGAAGTCATAGT-
GACAA-39) and sense primers (59-GGATCAGGGAAGTCCAG-
CTT-39) and cloned into the vector pGEM-T-easy (Promega). The
RNA-probes were synthesized using Sp6- or T7-RNA-polymerase and
labelled with Digoxigenin (DIG) using the DIG labelling reaction mix
(Roche). After de-waxing and post-fixation, paraffin embedded sections
of mice liver were digested with 10 mg/ml Proteinase K in 0.1 M Tris
pH 7.5 for 10 min at 37uC. The positively charged amino acids were
blocked by 0.1 M triethanolamine pH 8.0, 0.25% acetic acid
anhydride. Hybridization was performed overnight at 70uCi na
buffer containing 50% formamide, 56SSC pH 7.0, 16Denhardt’s
solution, 0.1% Tween20 and 0.1 mg/ml yeast tRNA (Roche). The
slides were washed under stringent conditions. The hybridization was
detected by probing with anti-DIG Fab fragments conjugated to
alkaline phosphatase (Roche) using BM purple substrate (Roche)
according to manufacturer’s instruction.
Cell culture
Established cell lines. L929 mouse fibroblasts, and TIB-75
hepatocytes were cultured in Iscove’s Modified Dulbecco’s Medium
(IMDM)supplemented with 10% FCS (Sigma-Aldrich, Deisenhofen,
Germany), 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/ml
penicillin, and 100 mg/ml streptomycin. Cells were induced with
mouse IFN-c (Cell Concepts) at a concentration of 200 U/ml for
24 h.
Murine primary hepatocytes. Hepatocytes were isolated
from liver using a two-step liver perfusion method (modified from
[31]). Mice were anaesthetized with 2–5 ml Avertin and injected
with 100 ml heparin-Na (5000 IU/ml). Mice were dissected and
the liver portal vein was canulated. The liver was first perfused
with pre-warmed (37uC) Krebs-Ringer-Buffer (KRB) (115 mM
NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 1.2 mM NaH2PO4,
1.2 mM Na2SO4, 2.5 mM CaCl2, 25 mM NaHCO3,1 0 m M
glucose) at a flow rate of 3 ml/min for 30 min, then with pre-
warmed 50 ml KRB with 1 mM EDTA, and finally with 100 ml
KRB with 0.5 mM CaCl2 and 0.05% collagenase (SIGMA) at the
same flow rate. Hepatocytes were liberated from the liver capsule
and filtered through 100 mm gauze. The cell suspension was
washed twice at 4uC with washing buffer (1xHanks buffer, 0.5%
BSA, 10 mM HEPES pH 7.65) at low speed (50 g) and then twice
with DMEM/Ham’s F12 1:1 Medium (Supplemented with 10%
FCS, insulin, transferrin and selenium (ITS, Roche) at 1%,
0.1 mM dexamethasone and 100 U/ml Penicillin/100 mg/ml
streptomycin buffered by 15 mM HEPES). Cells were then pre-
seeded for 15 min on collagen coated plates to eliminate tightly
adherent cells and then transferred to other collagen coated plates
for culture for several days. Note: All buffers and gauze were
sterilized and great care was taken when handing the cells to avoid
high mortality.
Immunofluorescence procedures
Immunofluorescence of cultured cells was performed as
described previously [32] and examined with an Axioplan II
fluorescence microscope equipped with an AxioCam MRm
camera using the Axiovision 4.7 software (all Zeiss).
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with 0.1% saponin and blocked with 3% BSA in PBS (Roth). The
cells were analyzed using a Zeiss (Oberkochen, Germany)
Axioplan II fluorescence microscope equipped with a cooled
charge-coupled device camera (Quantix; Photometrix, Tucson,
AZ).
Procedures involving Toxoplasma gondii
Tachyzoites from T. gondii strain ME49 were maintained by serial
passage in confluent monolayers of human foreskin fibroblasts (HS27,
ATCC) as described previously [11]. Mouse primary hepatocytes
were either left untreated or stimulated with IFN-c (R&D Systems) at
200 U/ml for 24 h prior to infection. For immunostaining,
hepatocytes were inoculated with T. gondii a taM O Io f3f o r2h .
Extracellular parasites were then removed by extensive washing with
PBS and cells were processed for immunostaining as above. Vacuoles
containing intracellular parasites were identified by immunostaining
for the T. gondii dense granule protein GRA7 that is associated with
the intravacuolar network and the PV membrane after infection
(reference).
Bioinformatics
Public databases (NCBI (http://www.ncbi.nlm.nih.gov) and
ENSEMBL (http://www.ensembl.org)) were screened for Irga6
with the Basic Local Alignment Search Tool, BLAST [33] to
identify ESTs and cDNAs that could clarify Irga6 59 exon usage.
The recovered sequences were aligned to distinguish ESTs based
on Exon 1A and exon 1B and to identify the splice site between
exon 1A or 1B and exon 2. Sequence alignments were performed
either with Vector NTI (InVitrogen), or using ClustalW2 at the
EBI-Sanger website (http://www.ebi.ac.uk/Tools/clustalw2/)
and edited manually. Shading of alignments was conducted with
GeneDoc (Version 2.6.002) (http://www.nrbsc.org) or JalView
(http://www.jalview.org/). Transcriptional start points for exon
1A and exon 1B were defined informally by the following criteria
and being the 59 base of the longest 59 extensions, confirmed by a
second sequence and present in the genomic sequence. Since the
genomic sequence standard for comparison was based on the
C57BL/6 genomic sequence for chromosome 18 (contig
NT_039674.7), cDNA sequences derived from C57BL/6 were
chosen to define the transcriptional start although longer plausible
59 extensions were found in ESTs from other mouse strains. The
regions up to 1000 bp upstream of the transcription start point
were designated as the putative promoter regions for each exon 1
of Irga6 and screened for transcription factor binding sites. ISRE
(IFN-stimulated response element), GAS (gamma-activated se-
quence), and hepatocyte nuclear factors HNF1 and HNF3 [34]
binding sites were detected with CONSITE (http://asp.ii.uib.
no:8090/cgi-bin/CONSITE/consite/, [35] and were confirmed
manually. HNF4 and HNF6 binding sites were identified by
manual comparison to published consensus binding sequences
[36–39].
Real-time PCR
Real-time quantitative polymerase chain reaction (qPCR)
analysis was performed in a Light Cycler I System using a
LightCycler SYBR Green I PCR kit (both Roche). The 59 primers
specific for Irga6 exon 1A (59-TGCTTCCTGAAGCTGAACTA-
39) and 1B exon (59-ACCGAGGGCTATTCCTCTCA-39) to-
gether with a common 39 primer for the coding exon (59-
CAGAGAAGGGATGATATTCAC-39) were used to detect and
distinguish Irga6 transcripts containing exons 1A and 1B.
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) specific
primers (59 primer 59-ATTAGCGATGATGAACCAGG-39,3 9
primer 59-TGGCCTATAGGCTCATAGTG-39) were used to
provide an input control. cDNA synthesized from mRNA
extracted from liver was used as PCR template The level of Irga6
transcript was normalized to that of HPRT in the same sample.
Melting curve analysis was performed after each run. Each sample
was tested in duplicate or triplicate. The quantitation of all
transcripts was achieved by comparison to an external standard
based on five serial tenfold dilutions of a pGEMTeasy plasmid
containing a full-length construct of Irga6 carrying the 59UT exon
1A; the dilutions ranged from 10
6 to 10
2 plasmid copies per assay.
Supporting Information
Table S1 Promoter HNF elements
Found at: doi:10.1371/journal.pone.0006787.s001 (0.03 MB
DOC)
Table S2 Directory of Irga gene sequence elements on
chromosome 18 genomic contig, NT_039674.7
Found at: doi:10.1371/journal.pone.0006787.s002 (0.06 MB
DOC)
Figure S1 Mouse EST sequences corresponding to Irga6 were
recovered from the public databases using Megablast. The figure
shows an alignment of all ESTs with extended sequence in the 59-
untranslated region. The genomic regions corresponding to
exon1A and exon 1B were identified from the C57BL/6
chromosome 18 contig, NT_039674.7, and are given at top and
bottom of the alignments. The splice boundary between both exon
1A and exon 1B and exon 2 is indicated by arrows above and
below the alignment. The last three bases of each EST sequence in
the alignment form the initial start codon of the Irga6 translated
protein. We used the 59 nucleotide of the two C57BL/6-derived
ESTs, AI116617 and AI662996, to define the start-point of
transcription for exon 1A and exon 1B respectively. These
correspond to nucleotide 57,535,681 of NT_039674.7 and for exon
1Aandnucleotide57,542342forexon1B(bothprintedinred).Non-
genomic 59 sequence extensions were removed from some EST
sequences before alignment. A splice variant of Irga6 was described
recently in IFN-induced mouse cells which carries both exon1A and
exon 1B in tandem in that order, with a short linker sequence
between them (NM_001146275) [16]. This is a unique case and
undoubtedly should not be considered a normal splice variant.
* indicates mouse strain of origin of EST. ** indicates ESTs from
libraries wheretheMus domesticusstrainoforiginwas notrecorded.
Found at: doi:10.1371/journal.pone.0006787.s003 (0.26 MB TIF)
Figure S2 Real-time PCR to analyze Irga6 expression in RNA
purified from different organs of adult C57/BL6 mice. Results are
presented as means with standard deviations from 4–5 indepen-
dent measurements, in each case normalised to the amount of
HPRT transcript. The 1A and 1B forms of Irga6 were
distinguished by 59 primers specific respectively for exon 1A and
exon 1B, while a common 39 primer in exon 2 was used.
Found at: doi:10.1371/journal.pone.0006787.s004 (1.24 MB TIF)
Figure S3 Western blots to assay Irgm3, Irgb6 and Irgm1 in
lysates of tissue culture cells and primary hepatocytes. A. From left
to right: Irgm3, assayed in L929 fibroblasts and TiB75 hepatocytes
after (+) and without (2) stimulation for 24 hr with 100 U/ml
IFNg; whole liver, and enriched primary hepatocytes cultured for
0, 3, 6, 12 and 24 h without IFNg, and lastly for 24 h with 100 U
IFNg (24+). Calnexin was assayed in each sample as a loading
control. B. From left to right, Irgb6 and Irgm1 assayed in TiB
hepatocytes without (2) and with (+) IFNg stimulation for 24 hr
with 100 U/ml; whole liver; enriched primary hepatocytes
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IFNg. Calnexin was assayed in each sample as a loading control.
Found at: doi:10.1371/journal.pone.0006787.s005 (0.38 MB TIF)
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